The threat posed by Zika presents an urgent need for vaccines and diagnostics.
As NACDS RxIMPACT continues to maximize the value of in-district congressional activities, a report from the pharmacy manager, Brandon Martin, PharmD, of Genoa, a QoL Healthcare Company, in Ladue, Mo., called a recent pharmacy tour with a field representative for Rep. Ann Wagner (R-MO), “the best type of legislative visit.”
NACDS represents members—by advocating on behalf of the pharmacy community with a resonant, unified voice about the value of pharmacy.
Last week NACDS, with support from the Association of State and Territorial Health Officials (ASTHO) and the Centers for Disease Control and Prevention (CDC), held a meeting to discuss strategies to improve public-private partnerships, which would lead to earlier and more broadly available pandemic vaccine.
Congress continues measures to address the nation’s opioid abuse epidemic. Yesterday, during the Senate Judiciary Committee’s Hearing on Oversight of the Drug Enforcement Administration (DEA), senior member and former chairman of the Committee Sen. Orrin Hatch (R-UT) asked DEA Acting Administrator Chuck Rosenberg what the DEA is doing to implement NACDS-backed legislation, S. 483, the Ensuring Patient Access and Drug Enforcement Act, which was signed into law on April 19, 2016.
You could have about 400,000 pharmacists available to help with your number one killer.
The Acetaminophen Awareness Coalition (AAC) highlighted research this week showing that progress is being made to increase awareness of the safe use of acetaminophen—one of the most common drug ingredients in the U.S.
Page 1 of 104